NCT05520723 2025-12-04
PRIMED
MedSIR
Phase 2 Completed
Clinical Trials
5 trialsNCT03094052 2025-06-26
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
University of California, San Francisco
Phase 2 Completed
NCT05252988 2025-04-01
DIANER
Spanish Breast Cancer Research Group
Phase 2 Active not recruiting
NCT03705442 2018-10-15
Probat-tmcc-17
University Hospital Rijeka
Phase 2 Unknown
NCT02323516 2015-12-08
ASPIDIA
Centre Francois Baclesse
Phase 2 Withdrawn